Avonex (interferon beta-1a) for multiple sclerosis
January 1996
The FDA will soon approve Avonex (interferon beta-1a) for multiple sclerosis.
It's a beta-interferon...similar to Betaseron.
Both Avonex and Betaseron help reduce the frequency of relapses in patients with the relapsing-remitting form of MS. In addition, Avonex also slows the progression of the disease.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote